Clinical Trial Update: Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Johns Hopkins University is evaluating atorvastatin for its effect on cerebrovascular reactivity in people with Mild Cognitive Imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Mild Cognitive Impairment | Phase 2 | Status: RECRUITING